---
title: "Mobia Medical, Inc. (MOBI.US)"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/MOBI.US.md"
symbol: "MOBI.US"
name: "Mobia Medical, Inc."
industry: "医疗器械"
datetime: "2026-05-16T03:16:59.879Z"
locales:
  - [en](https://longbridge.com/en/quote/MOBI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MOBI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MOBI.US.md)
---

# Mobia Medical, Inc. (MOBI.US)

## 公司概况

Mobia Medical, Inc. 开发和商业化神经刺激医疗设备，包括用于中风康复和其他神经系统疾病的植入系统。该公司提供结合迷走神经刺激与治疗的神经刺激系统和设备，以应对慢性神经系统疾病。其主要产品 Vivistim System 是一种获得 FDA 批准的植入设备，旨在帮助中风后患者的上肢运动功能康复

| 项目 | 详情 |
|------|--------|
| 行业 | 医疗器械 |
| 交易所 | US Market |
| 官网 | [www.mobia.com](https://www.mobia.com) |

## 关键驱动因素
> *AI 分析的影响该股票表现的关键因素*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Longbridge 独家多因子评级模型*
> 更新时间: 2026-05-15T04:30:13.000Z

**综合: B (0.26)**

**行业**: 医疗器械

| 指标 | 数值 |
|--------|-------|
| 行业排名 | 32 / 183 |
| 行业中位数 | C |
| 行业均值 | C |

- **风格**: 平衡型 - 公司有成长期业务也有成熟期业务的股票。
- **规模**: 小盘型 - 公司经营有较高的成长性和波动性，易于获得较高的投资收益。

**综合评分**: B

#### 风格得分 评分: 

| 指标 | 数值 | 评级 |
|-----------|-------|--------|
| 营业收入同比 | 104.81% |  |
| 净利润同比 | -88.99% |  |
| 市净率 | -2.64 |  |
| 股息率 | 0.00% |  |

#### 规模得分 评分: 

| 指标 | 数值 | 评级 |
|-----------|-------|--------|
| 市值 | 398678961.55 |  |
| 营业收入 | 32040978.00 |  |

#### 多维评分 评分: B

| 指标 | 数值 | 评级 |
|-----------|-------|--------|
| 净资产收益率（ROE） | 36.21% | A |
| 净利率 | -145.12% | E |
| 毛利率 | 81.07% | A |
| 营业收入同比 | 104.81% | A |
| 净利润同比 | -88.99% | E |
| 总资产同比 | 117.96% | A |
| 净资产同比 | 229.92% | A |
| 现金流净利率 | 98.27% | C |
| 运营现金流同比 | 104.81% | A |
| 资产周转率 | 0.91 | A |
| 资产负债率 | 39.77% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Mobia Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "风格得分",
      "grade": "",
      "indicators": [
        {
          "name": "营业收入同比",
          "value": "104.81%",
          "rating": ""
        },
        {
          "name": "净利润同比",
          "value": "-88.99%",
          "rating": ""
        },
        {
          "name": "市净率",
          "value": "-2.64",
          "rating": ""
        },
        {
          "name": "股息率",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "规模得分",
      "grade": "",
      "indicators": [
        {
          "name": "市值",
          "value": "398678961.55",
          "rating": ""
        },
        {
          "name": "营业收入",
          "value": "32040978.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "多维评分",
      "grade": "B",
      "indicators": [
        {
          "name": "净资产收益率（ROE）",
          "value": "36.21%",
          "rating": "A"
        },
        {
          "name": "净利率",
          "value": "-145.12%",
          "rating": "E"
        },
        {
          "name": "毛利率",
          "value": "81.07%",
          "rating": "A"
        },
        {
          "name": "营业收入同比",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "净利润同比",
          "value": "-88.99%",
          "rating": "E"
        },
        {
          "name": "总资产同比",
          "value": "117.96%",
          "rating": "A"
        },
        {
          "name": "净资产同比",
          "value": "229.92%",
          "rating": "A"
        },
        {
          "name": "现金流净利率",
          "value": "98.27%",
          "rating": "C"
        },
        {
          "name": "运营现金流同比",
          "value": "104.81%",
          "rating": "A"
        },
        {
          "name": "资产周转率",
          "value": "0.91",
          "rating": "A"
        },
        {
          "name": "资产负债率",
          "value": "39.77%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## 估值分析

| 指标 | 当前值 | 行业排名 | 最高 | 中位 | 最低 |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -8.47 | 141/183 | - | - | - |
| PB | -2.61 | 159/183 | - | - | - |
| PS (TTM) | 12.29 | 118/183 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## 同业比较

| 排名 | 名称 | 盈利 | 成长 | 运营 | 财务安全 | 现金流 | 评级 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | 直觉外科 (ISRG.US) | A | B | C | A | B | B |
| 04 | 史赛克 (SYK.US) | A | C | C | C | B | B |
| 05 | 波士顿科学 (BSX.US) | A | B | C | C | B | B |

## 参考链接

- [公司概况 — 简介、高管、股东、业务构成](https://longbridge.com/zh-CN/quote/MOBI.US/overview.md)
- [财务报表 — 利润表、资产负债表、现金流、分红方案](https://longbridge.com/zh-CN/quote/MOBI.US/norm.md)
- [相关新闻](https://longbridge.com/zh-CN/quote/MOBI.US/news.md)
- [公告 — 公司公告与监管文件](https://longbridge.com/zh-CN/quote/MOBI.US/filings.md)

---

> **免责声明: 本文仅供参考，不构成任何投资建议。**